Replies to post #206605 on Biotech Values

[dewophile]

SGEN

Adcetris is definitely more active in HL, but it does seem to have activity in CD30+ NHL as well. I'm curious to see the combo data w opdivo in NHL. Adcetris + opdivo in HL was just presented and showed a near doubling of the CR rate vs adcetris monotherapy in post transplant relapsers from 34% to 62%